NEW YORK, April 2 - Call it a love story born of supply and demand.

Despite their comparatively miniscule revenue base, publicly traded biotech companies, including genomics tool and tech firms, pay their CEOs considerably more than medical instrument or pharmaceutical companies, results of a recent survey show.


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.